MMP9 (Active Protein) mouse monoclonal antibody, clone 4A3, Purified
Applications | IHC, WB |
Reactivities | Human |
MMP9 (Active Protein) mouse monoclonal antibody, clone 4A3, Purified
Applications | IHC, WB |
Reactivities | Human |
IKK beta (IKBKB) mouse monoclonal antibody, clone 10A2, Ascites
Applications | ELISA, WB |
Reactivities | Human |
Rabbit Polyclonal Antibody against Beclin 1
Applications | ICC/IF, WB |
Reactivities | Human, Mouse |
CD68 mouse monoclonal antibody, clone 514H12, Supernatant
Applications | IF, IHC |
Reactivities | Human |
HLAB (HLA-B) mouse monoclonal antibody, clone BB7.1, FITC
Applications | FC |
Reactivities | Human |
CD79A mouse monoclonal antibody, clone ZL7-4, FITC
Applications | FC |
Reactivities | Human |
Myeloperoxidase (MPO) mouse monoclonal antibody, clone 2C7, FITC
Applications | FC |
Reactivities | Human |
CD45 mouse monoclonal antibody, clone CA12.10C12, Supernatant
Applications | FC, IHC |
Reactivities | Canine |
CD81 / TAPA1 hamster monoclonal antibody, clone Eat2, FITC
Applications | FC |
Reactivities | Mouse |
Myeloperoxidase (MPO) mouse monoclonal antibody, clone 2C7, PE
Applications | FC |
Reactivities | Human |
Cd34 rat monoclonal antibody, clone MEC14.7, FITC
Applications | FC |
Reactivities | Mouse |
Human IgG rabbit polyclonal antibody, Purified
Applications | Immunohistochemistry on Formalin-Fixed Paraffin Embedded Sections: Use at 1/200-1/500 dilution in an ABC method (30 minutes at room temperature). Proteolytic treatment is required prior to immunostaining of formalin fixed paraffin embedded tissue sections. Recommended Positive Control: Tonsil. |
Reactivities | Human |
Conjugation | Unconjugated |
Mouse monoclonal USP14 Antibody (N-term)
Applications | WB |
Reactivities | Human, Mouse, Rat |
Rabbit polyclonal HLA-DQB1 Antibody (N-term)
Applications | WB |
Reactivities | Human |
Rabbit polyclonal anti-CD46 antibody (Center Y354)
Applications | WB |
Reactivities | Human |